Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 378

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 378
---
 ”.

| Name                           | ​ | ​ | Age | ​ | ​ | Position                             | ​ |
| Chris Kim                      | ​ | ​ |  65 | ​ | ​ | Chief Executive Officer and Director | ​ |
| Scott Dam                      | ​ | ​ |  45 | ​ | ​ | Chief Financial Officer              | ​ |
| Byong C. Yoo, PhD              | ​ | ​ |  52 | ​ | ​ | Chief Science Officer                | ​ |
| Sang-jin Daniel Lee, PhD       | ​ | ​ |  54 | ​ | ​ | Head of Research & Development       | ​ |
| Beom K. Choi                   | ​ | ​ |  50 | ​ | ​ | Chief Technology Officer             | ​ |
| Eun Sook Lee, MD, PhD(1)(2)(3) | ​ | ​ |  61 | ​ | ​ | Independent Director                 | ​ |
| Nicholas Fernandez(1)(2)(3)    | ​ | ​ |  40 | ​ | ​ | Independent Director                 | ​ |
| Ji Yeon Baek(1)(2)(3)          | ​ | ​ |  53 | ​ | ​ | Independent Director                 | ​ |

(1) Member of the Audit Committee. (2) Member of the Nominating and Corporate Governance Committee. (3) Member of the Compensation Committee. Executive Officers Mr. Chris Kim, JD, LLM — President and Chief Executive Officer. Mr. Chris Kim has been Liminatus Pharma, LLC’s Chief Executive Officer and Managing Member since its founding in May 2018. From December 2016 to the present, he has also served as Chief Executive Officer of Viral Gene, Inc., Philadelphia, PA. From January 2007 to October 2017, he was Counsel for DeHeng Law Office NY, the largest law firm in China. Mr. Kim has over 30 years of experience in intellectual property law including patent, trademark, copyright, trade secret, unfair competition, and other related areas. Mr. Kim is a graduate of University of Pennsylvania Law School, LLM, SJD (C), M&A, Corporate Financing, Investment. He completed Saïd Business School, University of Oxford, Oxford Entrepreneurship: Venture Finance Programme, Certificate, 2019 – 2020, and the Harvard University Business School, Entrepreneurs Essentials, Certificate, 2018 – 2019. Mr. Scott Dam — Chief Financial